Highland Capital Management (Tennessee)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-50,000
Closed -$3.14M 420
2026
Q1
$3.14M Sell
50,000
-1,000
-2% -$80K 0.17% 137
2025
Q4
$4.86M Sell
51,000
-2,490
-5% -$244K 0.24% 94
2025
Q3
$5.22M Sell
53,490
-560
-1% -$58K 0.26% 91
2025
Q2
$5.81M Buy
54,050
+70
+0.1% +$7.08K 0.31% 83
2025
Q1
$5.45M Sell
53,980
-730
-1% -$73.5K 0.33% 80
2024
Q4
$4.89M Buy
+54,710
New +$4.82M 0.28% 87
2018
Q4
Sell
-29,739
Closed -$1.15M 311
2018
Q3
$1.15M Buy
29,739
+8,561
+40% +$299K 0.08% 208
2018
Q2
$693K Sell
21,178
-1,093
-5% -$33K 0.05% 248
2018
Q1
$608K Buy
22,271
+1,892
+9% +$51.4K 0.05% 259
2017
Q4
$505K Sell
20,379
-954
-4% -$26.3K 0.04% 278
2017
Q3
$622K Buy
21,333
+10,843
+103% +$299K 0.05% 244
2017
Q2
$291K Hold
10,490
0.02% 322
2017
Q1
$261K Sell
10,490
-60
-0.6% -$1.46K 0.02% 308
2016
Q4
$228K Sell
10,550
-3,431
-25% -$74.9K 0.02% 309
2016
Q3
$333K Sell
13,981
-9,979
-42% -$238K 0.03% 284
2016
Q2
$560K Sell
23,960
-12,745
-35% -$276K 0.05% 253
2016
Q1
$690K Sell
36,705
-76,059
-67% -$1.34M 0.06% 248
2015
Q4
$2.08M Sell
112,764
-68,269
-38% -$1.22M 0.17% 156
2015
Q3
$2.97M Sell
181,033
-2,350
-1% -$40.2K 0.25% 127
2015
Q2
$3.25M Buy
+183,383
New +$3.28M 0.25% 127

Other funds holding BSX

Highland Capital Management (Tennessee)'s BSX Position: Q2 2026 in Review

Highland Capital Management (Tennessee) sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 50,000 shares — an estimated $3.14M sold.

Highland Capital Management (Tennessee) first reported a position in BSX in Q2 2015 and held it in 20 quarters. The position peaked at $5.81M in Q2 2025. 659 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Highland Capital Management (Tennessee) reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Highland Capital Management (Tennessee) sold 50,000 Boston Scientific shares in Q2 2026, an estimated $3.14M.
  • Highland Capital Management (Tennessee) first reported a position in Boston Scientific in Q2 2015 and held it in 20 quarters.
  • Highland Capital Management (Tennessee)'s Boston Scientific position peaked at $5.81M in Q2 2025.
  • 659 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.